GlassScriptPhysician profile
Husain Rangwala
NPI 1194315291
$2,126.39
in general payments reported to CMS, 2019-2025
7 companies · $562 in 2025
The $562 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,261 · 2023: $17.63 · 2024: $286 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,428.46 | 2022-2025 | |
| Smith+Nephew, INC. | $458.50 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Mayne Pharma Commercial LLC | $95.94 | 2022-2025 | |
| Moximed, INC | $74.49 | 2025 | Misha Knee System, Small, Left |
| Vertex Pharmaceuticals Incorporated | $27.21 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $24.16 | 2025 | Dysport |
| Vericel Corporation | $17.63 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Husain Rangwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.